Insider Transactions in Q2 2023 at Rocket Pharmaceuticals, Inc. (RCKT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
John Militello |
SELL
Open market or private sale
|
Direct |
245
-3.85%
|
$5,145
$21.38 P/Share
|
|
May 17
2023
|
Kinnari Patel |
SELL
Open market or private sale
|
Direct |
1,330
-0.62%
|
$27,930
$21.38 P/Share
|
|
May 17
2023
|
Gaurav Shah CEO |
SELL
Open market or private sale
|
Direct |
4,122
-0.78%
|
$86,562
$21.38 P/Share
|
|
May 14
2023
|
John Militello |
BUY
Exercise of conversion of derivative security
|
Direct |
725
+10.23%
|
-
|
|
May 14
2023
|
Gaurav Shah CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,979
+1.49%
|
-
|
|
May 14
2023
|
Kinnari Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,989
+1.82%
|
-
|
|
Apr 21
2023
|
John Militello |
SELL
Open market or private sale
|
Direct |
2,342
-29.36%
|
$42,156
$18.65 P/Share
|
|
Apr 18
2023
|
John Militello |
BUY
Exercise of conversion of derivative security
|
Direct |
6,364
+44.37%
|
-
|
|
Apr 04
2023
|
Mark Andrew White |
BUY
Grant, award, or other acquisition
|
Direct |
76,662
+50.0%
|
-
|